| Literature DB >> 231736 |
H Ekert, K D Waters, I H Jurk, J Mobilia, P Loughnan.
Abstract
The antinausea and antivomiting effects of delta-9-tetrahydrocannabinol (THC) in children receiving cancer chemotherapy were compared with those of metoclopramide syrup and prochlorperazine tablets in two double-blind studies. THC was found to be a significantly better antinausea and antivomiting agent, but not all patients obtained relief of nausea and vomiting with THC. In some patients, THC enhanced appetite during a course of chemotherapy. In two patients, a "high" associated with THC administrationwas reported. Drowsiness was reported significantly more frequently with THC.Entities:
Mesh：
Substances：
Year: 1979 PMID： 231736
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738